Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Adagio Medical HoldingsADGM -13.38%11 3-Year ROIIC % is 16.86 as of Dec. 2025, which is at its 10-year median of 16.86. GuruFocus rates ADGM with a GF Score™ of 11/100. The stock has 2 warning signs investors should review. Among 796 Medical Devices & Instruments companies, Adagio Medical Holdings ranks better than 67.59% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Adagio Medical Holdings's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 16.86%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Adagio Medical Holdings's 3-Year ROIIC % or its related term are showing as below:
ADGM's 3-Year ROIIC % is ranked better than 67.59% of 796
companies
in the Medical Devices & Instruments industry
Industry Median: 1.52
vs ADGM: 16.86
Adagio Medical Holdings (NAS:ADGM) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Adagio Medical Holdings 3-Year ROIIC % Related Terms
Adagio Medical Holdings 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ADGM vs VNRX, PMI, SINT: 3-Year ROIIC % Comparison
For the Medical Devices subindustry, Adagio Medical Holdings's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adagio Medical Holdings 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Adagio Medical Holdings's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Adagio Medical Holdings's 3-Year ROIIC % falls into.
Adagio Medical Holdings 3-Year ROIIC % Calculation
Adagio Medical Holdings's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -21.89 (Dec. 2025) - -23.913 (Dec. 2022) )
/
( 24.859 (Dec. 2025) - 12.857 (Dec. 2022) )
=
2.023
/
12.002
=
16.86%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Adagio Medical Holdings (ADGM) has a 3-Year ROIIC % of 16.86 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Adagio Medical Holdings and its competitors. This is near median its historical median of 16.86. Over the past decade, Adagio Medical Holdings' 3-Year ROIIC % has ranged from 16.86 to 16.86. According to the industry distribution chart, Adagio Medical Holdings ranks #258 out of 796 companies in the Medical Devices & Instruments industry, placing it in the top 32.4%.
Is Adagio Medical Holdings' 3-Year ROIIC % too high?
Adagio Medical Holdings' current 3-Year ROIIC % of 16.86 is near median its 10-year median of 16.86. Over the past 10 years, this metric has ranged from a low of 16.86 to a high of 16.86. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.52. Adagio Medical Holdings' value of 16.86 is 1009.2% above this industry median. Based on the distribution chart, Adagio Medical Holdings ranks #258 out of 796 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Adagio Medical Holdings has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Adagio Medical Holdings' 3-Year ROIIC % compare to VNRX and PMI?
According to the Medical Devices & Instruments industry distribution chart, Adagio Medical Holdings ranks #258 out of 796 companies for 3-Year ROIIC %. This puts Adagio Medical Holdings in the upper half of its industry. The industry median 3-Year ROIIC % is 1.52. Adagio Medical Holdings' value of 16.86 is 1009.2% above this benchmark. Historically, Adagio Medical Holdings' own 3-Year ROIIC % has ranged from 16.86 to 16.86 over the past decade. While the company's 10-year median is 16.86 vs. the industry median of 1.52, Adagio Medical Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.52, based on 796 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Adagio Medical Holdings's current 3-Year ROIIC % of 16.86 is 1009.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Adagio Medical Holdings and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adagio Medical Holdings's current 3-Year ROIIC % is 16.86, which is near median its own 10-year median of 16.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adagio Medical Holdings stock overvalued right now?
Adagio Medical Holdings (ADGM) has a current 3-Year ROIIC % of 16.86. The current 3-Year ROIIC % is 16.86, which is near median its 10-year median of 16.86 and 1009.2% above the Medical Devices & Instruments industry median of 1.52. Adagio Medical Holdings' overall GF Score™ is 11/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Adagio Medical Holdings (ADGM), the current 3-Year ROIIC % is 16.86 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Adagio Medical Holdings Inc is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias with its proprietary, catheter-based Ultra-Low Temperature Ablation (ULTA) technology. UTLA is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The company is currently focused on the treatment of ventricular tachycardia (VT), a rapid, abnormal heart rhythm, or arrhythmia, that originates in the heart's lower chambers, or ventricles. The company has one reportable segment.
11GF Score
Get the complete analysis for ADGM
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ADGM has been successfully added to your 
